From: Cell-specific NFIA upregulation promotes epileptogenesis by TRPV4-mediated astrocyte reactivity
 | Manufacture | Dilution |
---|---|---|
Primary antibody | Â | Â |
 Anti-NFIA | Abcam (ab228897) | 1:1000 (WB) |
 |  | 1:200 (IF) |
 Anti-TRPV4 | Abcam(ab2040264) | 1:500 (WB) |
 |  | 1:200 (IF) |
 Anti-GFAP | CST(#3670) | 1:1000 (WB) |
 |  | 1:200 (IF) |
 |  | 1:200 (IHC) |
 Anti-C3 | Proteintech (21,337–1-AP) | 1:1000 (WB) |
 |  | 1:200 (IF) |
 |  | 1:1000 (WB) |
 Anti-S100A10 | Proteintech (11,250–1-AP) | 1:200 (IF) |
 Anti-IL-6 | Bioss(bs-0782R) | 1:1000 (WB) |
 Anti-IL-1β | CST(#12242S) | 1:500 (WB) |
 Anti-TNFα | ABclonal(A0277) | 1:1000 (WB) |
 Anti-HA | CST(C29F4) | 1:500 (WB) |
Secondary antibody | Â | Â |
 Goat anti-mouse IgG | Biosharp(BL001A) | 1:10,000 (WB) |
 Goat anti-rabbit IgG | Biosharp(BL003A) | 1:10,000 (WB) |
 HRP-conjugated anti-mouse antibody | Abbkine (A21010) | 1:500 (IHC) |